Military

Cramer Refutes the Sell Rating on Ceradyne (CRDN)

Cramer interviewed Joel Moskowitz, CEO of Ceradyne (CRDN), to end MAD MONEY on CNBC tonight.  Cramer said that the recent SELL rating from FBR on concerns of a potential demand cut from body armor causing a $9 drop recently is not right and they shouldn’t be scared.  The CEO said they have more 2007 body armor orders than they have ever had.  He said the US in 2007 and 2008 are indicating that they want to maintain high body armor levels in what may be for all field personnel, but that is from discussions rather than firm orders.  They have an 80,000 square foot facility they opened for the armor for trucks and they have $250 million in quotes that are pending on the table.  Cramer said that he is going with the bull case and he thinks the FBR research call for a Sell on the stock is Wrong.

Jon C. Ogg
January 22, 2007

Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.